An analysis of silybin meglumine tablets in the treatment of drug‐induced liver injury as assessed for causality with the updated Roussel Uclaf Causality Assessment Method using a nationwide database
British Journal of Clinical Pharmacology · 2023-04 · 89 (4) · 1329-1337
DOI: 10.1111/bcp.15575 ↗Kurz gefasst
Fachartikel in der Zeitschrift British Journal of Clinical Pharmacology, online erschienen am 10.11.2022. Verfasst von Bo Zhang und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Infectious Diseases, Tai'an Central Hospital, Taian, China. Hauptthemen laut MEDLINE: Chemical and Drug Induced Liver Injury, Silybin. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 23 Literaturangaben. Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
Aim
Drug‐induced liver injury (DILI) poses significant challenges to clinical practice. Currently, there is no recommended therapy to treat DILI; therefore, it is vital to explore new therapeutic agents. This study aimed to investigate the efficacy and safety of silybin meglumine tablets in treating DILI.
Methods
This study analysed 34 296 DILI cases assessed by the updated RUCAM from a nationwide database. A total of 301 patients with RUCAM scores ≥6 were directly enrolled in this study, while an additional 340 patients with RUCAM scores
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Infectious Diseases, Tai'an Central Hospital, Taian, China.
- Department of Infectious Diseases, Ningjin County People's Hospital, Ningjin, China.
- Department of Liver Disease, Public Health Clinical Center of Chengdu, Chengdu, China.
- Department of Liver Disease, Baoding People's Hospital, Baoding, China.
- Department of Infectious Diseases, Suining Central Hospital, Suining, China.
- Department of Liver Disease, Dazhou Central Hospital, Dazhou, China.
ORCID-Profile: Yimin Mao
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Zhang, B., Jiang, G., Wang, L., Li, X., Zhao, C., Tan, Q., Kang, W., Feng, Y., Han, X., Raza, H. K., & Mao, Y. (2023). An analysis of silybin meglumine tablets in the treatment of drug‐induced liver injury as assessed for causality with the updated Roussel Uclaf Causality Assessment Method using a nationwide database. British Journal of Clinical Pharmacology, 89(4), 1329-1337. https://doi.org/10.1111/bcp.15575
Vancouver
Zhang B, Jiang G, Wang L, Li X, Zhao C, Tan Q, et al. An analysis of silybin meglumine tablets in the treatment of drug‐induced liver injury as assessed for causality with the updated Roussel Uclaf Causality Assessment Method using a nationwide database. British Journal of Clinical Pharmacology. 2023;89(4):1329-1337. doi:10.1111/bcp.15575
BibTeX
@article{Zhang2023,
author = {Zhang, Bo and Jiang, Guosheng and Wang, Li and Li, Xia and Zhao, Chuan and Tan, Qiliang and Kang, Weiwei and Feng, Yuxia and Han, Xian and Raza, Hafiz Khuram and Mao, Yimin},
title = {An analysis of silybin meglumine tablets in the treatment of drug‐induced liver injury as assessed for causality with the updated Roussel Uclaf Causality Assessment Method using a nationwide database},
journal = {British Journal of Clinical Pharmacology},
year = {2023},
volume = {89},
number = {4},
pages = {1329--1337},
doi = {10.1111/bcp.15575}
}
EUVIMED